Core Viewpoint - The stock of Steady Medical (300888) has shown a slight increase, with a closing price of 39.68 yuan on December 1, 2025, reflecting a 0.66% rise, while the company has demonstrated strong financial performance in recent quarters [1][3]. Financial Performance - For the first three quarters of 2025, Steady Medical reported a main business revenue of 7.897 billion yuan, a year-on-year increase of 30.1% [3]. - The net profit attributable to shareholders for the same period was 732 million yuan, up 32.36% year-on-year, while the non-recurring net profit reached 679 million yuan, marking a 43.93% increase [3]. - In Q3 2025 alone, the company achieved a main business revenue of 2.601 billion yuan, a 27.71% increase year-on-year, and a net profit of 240 million yuan, up 42.11% year-on-year [3]. Market Position - Steady Medical's total market capitalization stands at 23.107 billion yuan, ranking third in the beauty and personal care industry [3]. - The company has a net asset value of 12.263 billion yuan, leading the industry, and a net profit of 732 million yuan, also ranking third [3]. - The company's price-to-earnings ratio (P/E) is 23.68, significantly lower than the industry average of 38.46, indicating a favorable valuation [3]. Investment Sentiment - Over the past 90 days, 20 institutions have rated the stock, with 17 buy ratings and 3 hold ratings, suggesting strong institutional confidence [4]. - The average target price set by institutions for the stock is 54.88 yuan, indicating potential upside from the current trading price [4].
股票行情快报:稳健医疗(300888)12月1日主力资金净卖出497.40万元